LEIF BERTELSEN DENTAL LABORATORIUM ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.4% 1.5% 1.6% 1.8% 5.0%  
Credit score (0-100)  80 77 73 70 43  
Credit rating  A A A A BBB  
Credit limit (kDKK)  13.6 9.4 3.9 0.8 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,450 1,502 1,440 1,463 1,060  
EBITDA  371 313 285 267 -140  
EBIT  315 236 216 200 -207  
Pre-tax profit (PTP)  311.5 230.4 209.1 194.1 -206.8  
Net earnings  256.0 176.6 163.1 147.6 -200.0  
Pre-tax profit without non-rec. items  311 230 209 194 -207  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  417 340 270 204 137  
Shareholders equity total  1,072 1,148 1,211 1,245 927  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,372 1,507 1,480 1,467 1,163  

Net Debt  -492 -710 -742 -639 -582  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,450 1,502 1,440 1,463 1,060  
Gross profit growth  16.6% 3.6% -4.2% 1.7% -27.5%  
Employees  0 0 0 0 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,372 1,507 1,480 1,467 1,163  
Balance sheet change%  19.1% 9.8% -1.8% -0.9% -20.7%  
Added value  370.5 313.5 285.2 269.9 -140.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  262 -155 -139 -134 -134  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  21.7% 15.7% 15.0% 13.7% -19.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  25.0% 16.4% 14.4% 13.6% -15.4%  
ROI %  31.7% 21.2% 18.1% 16.2% -18.5%  
ROE %  25.8% 15.9% 13.8% 12.0% -18.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  78.1% 76.2% 81.9% 84.8% 79.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -132.8% -226.5% -260.3% -239.0% 414.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.8 3.0 4.2 5.4 3.7  
Current Ratio  3.1 3.3 4.6 5.8 4.1  
Cash and cash equivalent  492.2 710.0 742.3 638.6 581.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  635.7 795.1 929.4 1,027.5 728.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -47  
EBIT / employee  0 0 0 0 -69  
Net earnings / employee  0 0 0 0 -67